Yingkun M. Xu

No. 107 Wenhua West Road, Lixia District
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

A motion-activated skeletal "Pacemaker" for systemic bone remodeling via oral piezoelectric microspheres.

A motion-activated skeletal "Pacemaker" for systemic bone remodeling via oral piezoelectric microspheres.

Journal: Bioactive materials

Published: April 02, 2026

Machine learning-driven multi-omics integration of urinary organic acids and ions enables precision risk stratification for calcium oxalate nephrolithiasis.

Machine learning-driven multi-omics integration of urinary organic acids and ions enables precision risk stratification for calcium oxalate nephrolithiasis.

Journal: Frontiers in medicine

Published: February 10, 2026

Single-Cell and Machine Learning Analyses Identify MYDGF as an Immune-Related Biomarker Associated With the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.

Single-Cell and Machine Learning Analyses Identify MYDGF as an Immune-Related Biomarker Associated With the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.

Journal: Human mutation

Published: February 05, 2026

Letter to the Editor: A deep learning framework to stratify Nottingham histologic grade 2 breast tumors based on dynamic contrast-enhanced MRI.

Letter to the Editor: A deep learning framework to stratify Nottingham histologic grade 2 breast tumors based on dynamic contrast-enhanced MRI.

Journal: European radiology

Published: December 28, 2025

Letter to the Editor: MRI-based habitat analysis for pathologic response prediction after neoadjuvant chemoradiotherapy in rectal cancer-a multicenter study.

Letter to the Editor: MRI-based habitat analysis for pathologic response prediction after neoadjuvant chemoradiotherapy in rectal cancer-a multicenter study.

Journal: European radiology

Published: October 14, 2025

Retraction Note: Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.

Retraction Note: Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.

Journal: Functional & integrative genomics

Published: May 20, 2024

Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer.

Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer.

Journal: Translational cancer research

Published: March 27, 2024

USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.

USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: October 08, 2023

GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway.

GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway.

Journal: International journal of oncology

Published: July 28, 2023

Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.

Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.

Journal: Oncology research

Published: April 07, 2023

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.

Journal: Frontiers in molecular biosciences

Published: April 06, 2023

Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.

Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.

Journal: Pathology, research and practice

Published: March 16, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026